Field Validation of Limiting-Antigen Avidity Enzyme Immunoassay to Estimate HIV-1 Incidence in Cross-Sectional Survey in Swaziland
Author:
Affiliation:
1. Division of Global HIV & TB, Centers for Disease Control and Prevention, Atlanta, Georgia.
2. ICAP at Columbia University, Mailman School of Public Health, New York, New York.
Publisher
Mary Ann Liebert Inc
Subject
Infectious Diseases,Virology,Immunology
Link
https://www.liebertpub.com/doi/pdf/10.1089/aid.2018.0284
Reference30 articles.
1. Combination HIV Prevention Interventions: The Potential of Integrated Behavioral and Biomedical Approaches
2. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study
3. Evaluation of a Sensitive/Less-Sensitive Testing Algorithm Using the 3A11-LS Assay for Detecting Recent HIV Seroconversion among Individuals with HIV-1 Subtype B or E Infection in Thailand
4. Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Continuous quality evaluation of the Asanté rapid test for recent infection for robust kit lot quality verification;PLOS Global Public Health;2024-05-14
2. A Human Immunodeficiency Virus Type 1 Risk Assessment Tool for Women Aged 15–49 Years in African Countries: A Pooled Analysis Across 15 Nationally Representative Surveys;Clinical Infectious Diseases;2024-04-24
3. Adult HIV-1 incidence across 15 high-burden countries in sub-Saharan Africa from 2015 to 2019: a pooled analysis of nationally representative data;The Lancet HIV;2023-03
4. HIV Incidence, Recent HIV Infection, and Associated Factors, Kenya, 2007–2018;AIDS Research and Human Retroviruses;2023-02-01
5. Facilitating Next‐Generation Pre‐Exposure Prophylaxis Clinical Trials UsingHIVRecent Infection Assays: A Consensus Statement from the ForumHIVPrevention Trial Design Project;Clinical Pharmacology & Therapeutics;2023-01-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3